Urgent plasma exchange: How, where and when

Blood Transfusion

Volumn 9, Issue 4, 2011, Pages 356-361

  Russi, Gianpaolo ^a   Marson, Piero ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Emergency; Therapeutic plasma exchange; TPE

Indexed keywords

AMINOQUINOLINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CARBAMAZEPINE; CISPLATIN; CITRIC ACID; CORTICOSTEROID; DILTIAZEM; FRESH FROZEN PLASMA; GLUCONATE CALCIUM; LEVOTHYROXINE; PHENYLBUTAZONE; PHENYTOIN; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VERAPAMIL; VINCRISTINE;

ACID BASE BALANCE; ACUTE PANCREATITIS; ANTIPHOSPHOLIPID SYNDROME; BLOOD PRESSURE MONITORING; DRUG INTOXICATION; EDITORIAL; EMERGENCY; HEMODYNAMICS; HEPATITIS; HUMAN; HYPERTRIGLYCERIDEMIA; HYPERVISCOSITY SYNDROME; INTENSIVE CARE UNIT; MEDICAL STAFF; MYASTHENIA GRAVIS; NURSING STAFF; PLASMAPHERESIS; RESPIRATORY FUNCTION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VEIN PUNCTURE;

BLOOD COMPONENT REMOVAL; EMERGENCY TREATMENT; HUMANS; PLASMA EXCHANGE; PRACTICE GUIDELINES AS TOPIC;

EID: 80054963227     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2011.0093-10     Document Type: Editorial

References (16)

1. McLeod BC. Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion 2010; 50:1413-26.
2. Szczepiorkowski ZM, Winters JL, Bandarenko N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apheresis 2010; 25: 83-177.
3. Atkins D, Best D, Briss PA, et al. for the GRADE Working Group. Grading quality for evidence and strength of recommendations. BMJ 2004; 328:1490-7.
4. Linenberger ML, Price TH. Use of cellular and plasma apheresis in the critically ill patient: part 1: technical and physiological considerations. J Intensive Care Med 2005; 20: 18-27. (Pubitemid 43093905)
5. Zeigler ZR, Shadduck RK, Gryn JF, et al. Cryoprecipitate-poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). J Clin Apheresis 2001; 16: 19-22. (Pubitemid 32374499)
6. George JN. Evolution and management of patients with thrombotic thrombocytopenic purpura. J Intensive Care Med 2007; 22: 82-91. (Pubitemid 46548125)
7. Vora SK, Asherson RA, Erkan D. Catastrophic antiphospholipid syndrome. J Intensive Care Med 2006; 21: 144-59.
8. Marson P, Bagatella P, Bortolati M, et al. Plasma exchange for the management of the catastrophic antiphospholipid syndrome. Importance of the type of fluid replacement J Int Med 2008; 264: 201-3. (Pubitemid 351962575)
9. Ewald N, Kloer HU. Severe hypertriglyceridemia: an indication for apheresis? Atheroscler Suppl 2009; 10: 49-52.
10. Samtleben W, Mistry-Burchardi N, Hartmann B, et al. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001; 5: 351-7. (Pubitemid 34033332)
11. De Silvestro G, Marson P, Brandolese R, et al. A single institution experience (1982-1999) with plasma exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs 2000; 23: 454-61. (Pubitemid 30636097)
12. Adams BD, Baker R, Lopez JA, Spenser S. Myeloproliferative disorders and the hyperviscosity syndrome. Emerg Med Clin N Am 2009; 27: 459-76.
13. Ballestri M, Ferrari F, Magistroni R, et al. Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study. Ann Ist Super Sanità 2007; 43: 171-5.
14. Bianchin G, Russi G, Romano N, Fioravanti P. Treatment with HELP-apheresis in patients suffering from sudden sensorineural heating loss: a prospective, randomized, controlled study. Laryngoscope 2010; 120: 800-7.
15. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence-based guideline update: plasmapheresis in neurological disorders. Neurology 2011; 76: 294-300.
16. Natarjan N, Weinstein R. Therapeutic apheresis in neurology critical care. J Intensive Care Med 2005; 20: 212-25. (Pubitemid 43093892)